Vivos (RDGL) EPS (Basic) (2010 - 2025)

Vivos (RDGL) posted EPS (Basic) of -$0.0 for Q4 2025, down 113.34% sequentially from -$0.0 in Q3 2025, and up 4.62% YoY from -$0.0 in Q4 2024.

Vivos (RDGL) EPS (Basic) (2010 - 2025) Analysis & Trends

Vivos has reported EPS (Basic) for 16 years, with the latest figure at -$0.0 in Q4 2025.

Quarterly EPS (Basic) rose 4.62% year-over-year to -$0.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$0.01 (up 4.67% YoY) and the FY2025 annual result came in at -$0.01, up 4.67% from the prior year.
EPS (Basic) declined to -$0.0 in Q4 2025 per RDGL's latest filing, from -$0.0 in the prior quarter.
Over five years, EPS (Basic) peaked at -$0.0 in Q4 2021 and troughed at -$0.01 in Q2 2021.
A 5-year average of -$0.0 and a median of -$0.0 in 2025 frame the typical range for EPS (Basic).
The sharpest annual moves came in 2021 and 2023: EPS (Basic) slumped 517.02% in 2021, then soared 66.37% in 2023.
Over 5 years, EPS (Basic) stood at -$0.0 in 2021, then plunged by 267.11% to -$0.0 in 2022, then slumped by 45.33% to -$0.0 in 2023, then grew by 14.41% to -$0.0 in 2024, then increased by 4.62% to -$0.0 in 2025.
According to Business Quant data, EPS (Basic) over the past three periods registered -$0.0, -$0.0, and -$0.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EPS (Basic) (Qtr)
1	Abbott Laboratories	200.19 Bn	194.59 Bn	7.27 Bn	0.53
2	Stryker	129.95 Bn	126.47 Bn	4.50 Bn	3.33
3	Medtronic	120.06 Bn	110.84 Bn	6.41 Bn	0.98
4	Boston Scientific	74.14 Bn	73.60 Bn	3.85 Bn	0.62
5	Edwards Lifesciences	52.74 Bn	48.49 Bn	1.35 Bn	0.42
6	Dexcom	34.60 Bn	32.65 Bn	830.00 Mn	0.65
7	GE HealthCare Technologies	34.20 Bn	32.10 Bn	2.18 Bn	1.27
8	Koninklijke Philips	26.46 Bn	23.13 Bn	4.55 Bn	0.65
9	Steris	23.25 Bn	22.77 Bn	684.20 Mn	2.06
10	Vivos	24.90 Mn	23.34 Mn	-3,105.00	0.00

Download Data